Cardiovascular Risk Assessment Tools are Insufficient for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. uri icon

authors

  • Barritt, A Sidney
  • Loomba, Rohit
  • Sanyal, Arun
  • Tapper, Elliot B
  • Newsome, Philip N
  • Gazis, Derek
  • BSN, RN
  • Mospan, Andrea R
  • Perez, Anthony Daniel
  • Kim, Yestle
  • Neuschwander-Tetri, Brent A

publication date

  • June 11, 2025